CATX

Q: What is the price of Perspective Therapeutics Inc. (CATX) today?

The price of Perspective Therapeutics Inc. (CATX) today is US$ 4,49, with a variation of -63.05% compared to the last year. The price of Perspective Therapeutics Inc. (CATX) started the year trading around US$ 3,19 and today it is at US$ 4,49. Follow the real-time price chart, the historical price of Perspective Therapeutics Inc. (CATX), and stock data from Ibovespa and international markets.

Q: When does Perspective Therapeutics Inc. (CATX) pay dividends?

Perspective Therapeutics Inc. (CATX) não distribuiu dividendos no último ano.

Q: Perspective Therapeutics Inc. (CATX) is it worth it?

Currently, Perspective Therapeutics Inc. (CATX) is priced at US$ 4,49, with a P/E of -3,55%, representing a deviation of -4,39% from its historical average P/E. In the last year, the stock showed a variation of -63.05% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -63,05%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Perspective Therapeutics Inc. (CATX)?

Investing in stocks of Perspective Therapeutics Inc. (CATX) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Perspective Therapeutics Inc. (CATX) yield today?

The yield of Perspective Therapeutics Inc. (CATX) was 47,70% in the last month, -63,05% in the last year and -21,23% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Perspective Therapeutics Inc. (CATX) today, the total investment would be US$ 449,00, based on the current price of US$ 4,49.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 165,91In 5 years: US$ 353,68In 10 years: 140,99It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Perspective Therapeutics Inc.

Price

US$ 4,49

variation (12m)

-63,05%

p/l

-3,55

p/vp

1,35

DIVIDEND YIELD

0,00%

price CATX

BVMF

CATX

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of CATX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

47,70%

3 months

6,90%

1 year

-63,05%

2 years

60,36%

5 years

-21,23%

10 years

-68,60%

real profitability

profitability minus inflation.

1 month

47,70%

3 months

6,51%

1 year

-64,67%

2 years

46,36%

5 years

-41,79%

10 years

-81,20%

Indicators CATX

check out the fundamentals of Perspective Therapeutics Inc. shares

P/E

-3,55

Sector: 8,28 Industry: 8,28

P/SALES RATIO (PSR)

Sector: 2,55 Industry: 2,55

P/BV

1,35

Sector: 2,32 Industry: 2,32

DIVIDEND YIELD (DY)

0,00%

Sector: 0,89% Industry: 0,89%

ROA

-32,60%

Sector: 1,02% Industry: 1,02%

ROE

-38,13%

Sector: 5,45% Industry: 5,45%

ROIC

-80,72%

Sector: -44,81% Industry: -44,81%

NET MARGIN

0,00%

Sector: 3,74% Industry: 3,74%

GROSS MARGIN

0,00%

Sector: 32,75% Industry: 32,75%

OPERATING MARGIN

0,00%

Sector: 5,13% Industry: 5,13%

P/EBITDA

-3,55

Sector: 2,48 Industry: 2,48

P/EBIT

-3,45

Sector: -0,15 Industry: -0,15

P/ASSET

1,16

Sector: 1,17 Industry: 1,17

BVPS

3,59

Sector: 9,70 Industry: 9,70

EPS

-1,37

Sector: 0,77 Industry: 0,77

EQUITY / ASSETS

0,86

Sector: 0,43 Industry: 0,43

CAGR REVENUES 5 YEARS

0,00%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

94,57%

Sector: - Industry: -

CATX indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
META	23,95	9,10	38,02%	0,29%	US$ 1,78 T	39,93%
INTR	17,79	2,19	12,32%	0,95%	US$ 3,71 B	15,52%
PBR	5,90	1,02	17,20%	16,96%	US$ 74,75 B	15,08%
PLTR	543,58	68,86	12,67%	0,00%	US$ 414,92 B	22,19%
VALE	9,22	1,12	12,18%	6,67%	US$ 45,52 B	13,76%
SHEL	16,45	1,16	7,05%	3,97%	US$ 212,40 B	4,85%
MAIN	9,16	1,70	18,56%	7,64%	US$ 4,90 B	86,83%
BDORY	9,46	0,65	6,89%	7,73%	US$ 21,92 B	9,29%
STLA	38,82	0,33	0,86%	7,28%	US$ 28,28 B	0,22%
ENB	19,26	2,08	10,80%	5,64%	US$ 103,96 B	11,73%
NSRGY	9,84	6,79	69,01%	3,60%	US$ 242,66 B	11,63%
BBSEY	7,33	6,14	83,87%	12,61%	US$ 11,63 B	100,00%
UNH	17,24	3,07	17,80%	2,43%	US$ 321,53 B	4,30%
SAN	10,13	1,21	11,94%	2,33%	US$ 152,05 B	22,41%
TTE	9,78	1,08	11,08%	4,63%	US$ 128,88 B	7,15%
TD	6,63	1,47	22,16%	3,81%	US$ 134,48 B	47,06%
ITUB	9,57	1,85	19,34%	7,42%	US$ 72,90 B	28,45%

comparison of CATX with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History CATX

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Perspective Therapeutics Inc.

Perspective Therapeutics Inc.

Average user rating I10

4.0 (1 people)

Estados Unidos

- year

Foundation:

Year of debut on the stock exchange - - year

-

Employees

The Company Perspective Therapeutics Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 359,64 Milhões, having a net worth of $ 265,69 Milhões.

The Company is listedthe in the sector of Others and categorized in industry of Others.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -101,31 Milhões.

As for its main indicators, the Company has a P/E ratio of -3,55, a P/BV ratio of 1,35 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker CATX.

Market value

US$ 359,64 Milhões

Net worth

US$ 265,69 Milhões

US$ 265.690.000,00

Assets

US$ 310,73 Milhões

US$ 310.730.000,00

Total Number of Shares

74,00 Milhões

74.000.000

Average Daily Trading Volume

US$ 837,16 Thousand

US$ 837.158,00

Sector

Others

Industry

Others

CATX

CATX revenue and profits

CATX results

DRAG THE FRAME TO SEE MORE DATA

CATX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CATX

Perspective Therapeutics Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of CATX

check out the fundamentals of Perspective Therapeutics Inc. shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Perspective Therapeutics Inc.

Perspective Therapeutics Inc.

Estados Unidos

- year

-

PROFIT X PRICE CATX

CATX results

CATX cash flow

evolution of assets - CATX

CATX balance sheet

UNH - UnitedHealth Group Incorporated

CRERF - Carrefour SA

STLA - Stellantis NV

COR - Cencora Inc.

SHEL - Shell PLC ADR

ELV - Elevance Health Inc

BLSH - Bullish

BBDO - Banco Bradesco S/A ADR

UNH - UnitedHealth Group Incorporated

CRERF - Carrefour SA

STLA - Stellantis NV

COR - Cencora Inc.

SHEL - Shell PLC ADR

ELV - Elevance Health Inc

BLSH - Bullish

BBDO - Banco Bradesco S/A ADR

Frequently Asked Questions